Calcitonin Linked to an Increased Cancer Risk
The European Medicines Agency (EMA) warned that calcitonin-containing medicines should only be used for short-term treatment because of evidence that long-term use of these medicines is associated with an increased risk of cancer. It also recommended that nasal sprays with calcitonin - used to treat osteoporosis - be withdrawn,